Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer
Poplin E, LoRusso P, Lokich J, Gullo J, Leming P, Schulz J, Veach S, McCulloch W, Baker L, Schein P. Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer. Cancer Chemotherapy And Pharmacology 1994, 33: 415-419. PMID: 8306416, DOI: 10.1007/bf00686271.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAmifostineBone Marrow DiseasesColorectal NeoplasmsFemaleHumansMaleMiddle AgedMitomycinConceptsColorectal cancerMyelosuppressive potentialRefractory colorectal cancerMetastatic colorectal cancerAdvanced colorectal cancerRandomized clinical trialsUse of mitomycinRefractory colorectal carcinomaMitomycin therapyPlatelet nadirsHematologic toxicityPrincipal toxicityPartial responseClinical trialsColorectal carcinomaSame dosePatientsMitomycinCancerThrombocytopeniaTherapyToxicityGroupPretreatmentFluorouracil